222834-11-9

Basic information

• Product Name: (+/-)-methyl 3-(4-(2-(10H-phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoate
• CAS NO: 222834-11-9
• Molecular Weight: 433.504
• Mol File: 222834-11-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (+/-)-methyl 3-(4-(2-(10H-phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-methyl 3-(4-(2-(10H-phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoate(222834-11-9)
• EPA Substance Registry System: (+/-)-methyl 3-(4-(2-(10H-phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoate(222834-11-9)

Safety Data

• Hazardous Substances Data: 222834-11-9(Hazardous Substances Data)

Upstream product

• 156335-15-8 2-ethoxy-3-(4-hydroxy-phenyl)-propionic acid methyl ester 
• 222835-09-8 2-(10H-Phenoxazin-10-yl)ethyl methanesulfonate 
• 92199-64-9 2-(10H-phenoxazin-10-yl)-1-ethanol 
• 59012-91-8 2,2-dimethyl-propionic acid 4-hydroxymethyl-phenyl ester 
• 623-05-2 (4-hydroxyphenyl)methanol 
• 135-67-1 phenoxazine 
• 302344-84-9 ethyl 2-(10H-phenoxazin-10-yl)acetate 
• 67-56-1 methanol 

Downstream Products

• 222834-28-8 [(2S),N(1S)]-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxy-N-(2-hydroxy-1-phenylethyl)propanamide 
• 222834-30-2 ragaglitazar 
• 222834-30-2 (-)-2-ethoxy-3-(4-(2-phenoxazin-10-yl-ethoxy)-phenyl)-propionic acid 

Relevant articles and documents

Asymmetric phase-transfer catalyzed glycolate alkylation, investigation of the scope, and application to the synthesis of (-)-ragaglitazar

Asymmetric glycolate alkylation using a protected acetophenone surrogate under solid-liquid phase-transfer conditions is a new approach to the synthesis of 2-hydroxy esters and acids. Diphenylmethyloxy-2,5-dimethoxyacetophenone 1 with a trifluorobenzyl ci

Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them

Novel beta -aryl- alpha -oxysubstituted alkylcarboxylic acids of the formula (I) and compositions containing them. The compounds have hypolipidemic, antihyperglycemic uses.